Evaluating pancreatic radiofrequency treatment for tumors
Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
This study is testing if ultrasound-guided radiofrequency treatment can effectively help people with pancreatic tumors over five years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche Academic / other |
| Locations | 1 site (Toulon) |
| Trial ID | NCT05871164 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the oncological efficacy of ultrasound-guided pancreatic radiofrequency treatment for tumors over a five-year period. Patients requiring treatment will be enrolled and monitored through multiple follow-up visits after the procedure to evaluate their response rates based on established criteria. The study is non-randomized and will adhere to current clinical practices for patient care.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are being treated for pancreatic tumors and can consent to follow-up visits.
Not a fit: Patients with contraindications to radiofrequency treatment or those who are pregnant or breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the effectiveness of pancreatic radiofrequency treatment, potentially improving outcomes for patients with pancreatic tumors.
How similar studies have performed: While there have been studies on radiofrequency treatments for various tumors, this specific approach for pancreatic tumors is less common and may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years old; * Patient to be treated for a pancreatic tumor by ultrasound-guided RF with a fine needle; * Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting; * Patient able to understand the information related to the study; * Patient accepting study follow-up visits; * Patient having been informed and agreeing to participate in the study. Exclusion Criteria: * Patient with a contraindication to radiofrequency treatment; * Pregnant or breastfeeding women
Where this trial is running
Toulon
- CHI Toulon La Seyne — Toulon, France (Recruiting)
Study contacts
- Study coordinator: Bertrand NAPOLEON, MD
- Email: dr.napoleon@wanadoo.fr
- Phone: 428636969
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.